MAR 31, 2020 9:00 AM PDT

Impact of liquid biopsy in advanced HER2+ breast cancer tumors: a follow-up study

Speaker

Abstract
DATE:  March 31, 2020
TIME:  9:00am PT, 12:00pm ET
 
HER2-positive breast cancer is a type of breast cancer caused by over-expression of a protein called human epidermal growth factor receptor 2 (HER2). While this aggressive breast cancer is highly curable, with 10 year survival rates at an average of >70%, it is also highly prevalent – with this gene mutation being detected in 1 out of every 5 breast cancer cases. In addition to chemotherapy, there are multiple targeted therapies approved for treatment of HER2+ breast cancer. However, HER2+ breast cancer also has a high recurrence rate, increasing the chances of the cancer metastasizing.
 
In today's presentation, Dr. Allegretti will discuss his clinical research work on HER2+ metastatic breast cancer samples using liquid biopsy (LB) analysis. This study aims to determine feasibility of profiling and tracking over time the molecular behavior of advanced HER2+ breast cancer tumors during drug treatments. Analysis is conducted using two different LB techniques - next-generation sequencing (NGS) and digital PCR (dPCR). Results strongly encourage the integration of LB analysis with genomic assessment from tumor tissues. Together, these complementary techniques may be able to provide compelling evidence to uncover resistance/response mechanisms in the future, potentially yielding valuable clinical information for better cancer management strategies.
 
Learning Objectives:
  • Investigate advantages of analyzing advanced HER2+ metastatic breast cancer tumor samples with Liquid Biopsy 
  • Demonstrate the complementary nature of dPCR and NGS Liquid Biopsy analysis
  • Illustrate the advantages of combined tissue biopsy and Liquid Biopsy analyses
 
 
 
Webinars will be available for unlimited on-demand viewing after live event.
 
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

 


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
JUL 15, 2021 9:00 AM PDT
JUL 15, 2021 9:00 AM PDT
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
NOV 17, 2021 8:00 AM PST
C.E. CREDITS
NOV 17, 2021 8:00 AM PST
Date: November 17, 2021 Time: 8:00am (PDT), 11:00am (EDT) From waste disposal to promising biomarkers and therapeutic agents, exosomes and other extracellular vesicles are valuable in resear...
JUL 15, 2021 8:00 AM PDT
C.E. CREDITS
JUL 15, 2021 8:00 AM PDT
Date: July 15, 2021 Time: 8:00am (PDT), 11:00am (EDT) High dimensional full spectrum flow cytometry grants unprecedented access to previously unattainable parameters in cellular biology. Flu...
Loading Comments...
Show Resources